Antibodies, antigens, and anticoagulants: A historical review of a lifetime in transfusion medicine - The Landsteiner Lecture 2004

Transfusion

Volumn 45, Issue 9, 2005, Pages 1531-1539

  Greenwalt, Tibor J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP; CONFERENCE PAPER; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; HISTORY OF MEDICINE; MEDICAL PRACTICE; NEWBORN HEMOLYTIC DISEASE; PERSONAL EXPERIENCE; TRANSFUSION; ARTICLE; BLOOD TRANSFUSION; HISTORY; HUMAN; UNITED STATES;

ANTIBODY; ANTICOAGULANT AGENT; ANTIGEN;

ANTIBODIES; ANTICOAGULANTS; ANTIGENS; BLOOD TRANSFUSION; HISTORY, 20TH CENTURY; HUMANS; UNITED STATES;

EID: 26944481641     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00572.x     Document Type: Conference Paper

References (110)

1. Landsteiner K. Zur kenntniss der antifermentativen, lyteischen und agglutinier enden wirkungen des blutserums und der lymphe. Zentralbl Bakteriol 1900;14:357-62.
2. Landsteiner K. Ueber agglutinationsercheinungen normalen menschlichen blutes. Wien Klin Wochenschr 1901;14:1132-4.
3. von Decastello A, Sturli A. Ueber di iso-agglutinine im serum gesunder und kranker menschen. Munch Med Wochenschr 1902;49:1090-5.
4. Diamond L, Blackfan K, Baty J. Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum, and anemia of the newborn. J Pediatr 1932;1:269-309.
5. Levine P, Burnham L. Isoimmunization in pregnancy: its possible bearing on the etiology of erythroblastosis fetalis. JAMA 1941;116:825-8.
6. Demeshek W, Greenwalt TJ, Tat RJ. Erythroblastosis fetalis (acute hemolytic anemia of the newborn: preliminary report). Am J Dis Child 1943;65:571-81.
7. Tat RJ, Greenwalt TJ, Demeshek W. Output of bile pigment by newborn infants and children. Am J Dis Child 1943;65: 558-70.
8. Greenwalt TJ. Tuberculoid leprosy: a case report. Ann Intern Med 1945;22:282-7.
9. Greenwalt TJ. Intestinal coccidiosis. Field Med Bull India Burma Theater 1945;4:282-5.
10. Teague BT, Levin WC. The explosion that produced the American Association of Blood Banks. Transfusion 1997;37:1209-10.
11. Carter BB. Preliminary report on a substance which inhibits anti-Rh serum. Am J Clin Pathol 1947;17:646.
12. Carter BB. Studies on the Rh hapten. Penn Med J 1948;52:124.
13. Carter BB. Rh hapten: its preparation, assay and nature. J Immunol 1949;61:79.
14. Greenwalt TJ. Experiences with "Rh hapten." Proceedings of the 2nd Annual Meeting of the American Association of Blood Banks; Seattle, WA; 1949. p. 12-34.
15. Greenwalt TJ. A critical appraisal of the present status of "Rh hapten." Wis Med J 1950;49:711-2.
16. Greenwalt TJ. Preparation, assay and clinical experiences with Rh hapten. Proc Soc Hematol 1950:197-205.
17. Wiener AS, Wexler IB, Gamrin E. Hemolytic disease of the fetus and the newborn infants with special reference to transfusion therapy and the use of the biological test for detecting Rh sensitivity. Am J Dis Child 1944;68:317.
18. Wallerstein H. Erythroblastosis and its treatment. Lancet 1946;2:922-4.
19. Diamond LK. Replacement transfusion as a treatment of erythroblastosis fetalis. Pediatrics 1948;2:520-4.
20. Greenwalt TJ. The use of red cell mass in replacement transfusion for hemolytic disease of the newborn. Proceedings the Third Annual Meeting of the AABB; Chicago, IL; 1951. p. 139-55.
21. Greenwalt TJ. Erythroblastosis fetalis. Proceedings of the Fourth Annual Meeting of the AABB; Minneapolis, MN; 1951.
22. Greenwalt TJ. Notes on the management of hemolytic disease of the newborn. J Wisconsin Assoc Med Tech 1953;November-December:12-4.
23. Greenwalt TJ, Sasaki TT, Sanger R, Sneath J, Race RR. An allele of the S(s) blood group genes. Proc Natl Acad Sci U S A 1954;40:1126-9.
24. u Blood group genes in American Negroes. Vox Sang 1955;5:73-81.
25. Greenwalt TJ, Sanger R. The Rh antigen Ew. Br J Haematol 1955;1:52-4.
26. a. Blood 1957;12:998-1003.
27. Greenwalt TJ. Confirmation of linkage between the Lutheran and secretor genes. Am J Hum Genet 1961;13:69-88.
28. Greenwalt TJ. Practical applications of recent advances in the red cell blood groups with emphasis on the rarer types. Prog Hematol 1962;3:71-91.
29. Greenwalt TJ, Gajewski M. The central file for rare donors. Transfusion 1962;2:194-7.
30. Gajewski M, Greenwalt TJ. The central file for rare donors and frozen blood program of the American Association of Blood Banks. Am J Med Technol 1965;31:175-85.
31. Greenwalt TJ. The birth of TRANSFUSION. Transfusion 1997;37:1206-8.
32. Crawford MN, Greenwalt TJ, Sasaki TT, et al. The phenotype Lu(a-b-) together with unconventional Kidd groups in one family. Transfusion 1961;1:228-32.
33. Greenwalt TJ, Sasaki TT, Steane EA. The development of the Lutheran blood groups after birth. Bibl Haematol 1968;29:340-2. 340-2.
34. Greenwalt TJ, Sasaki TT, Steane EA. The Lutheran blood groups: a progress report with observations on the development of the antigens and characteristics of the antibodies. Transfusion 1967;7:189-200.
35. Chandanayingyong D, Sasaki TT, Greenwalt TJ. Blood groups of the Thais. Transfusion 1967;7:269-76.
36. b of the Sutter blood group system. Transfusion 1963;3:94-9.
37. b, the expected antithetical antibody of the Sutter blood group system. Nature 1963;197:295-6.
38. b of the Sutter blood group system. Bibl Haematol 1964;19:235-7.
39. Greenwalt TJ. The red cells in hemolytic disease of the newborn. Bibl Haematol 1964;19:370-4.
40. Greenwalt TJ, Morell SA, Ayers VE. Phosphate partition in the erythrocytes of normal newborn infants and infants with erythroblastosis fetalis. IV. Ion exchange chromatography. Blood 1963;22:589-99.
41. Greenwalt TJ, Ayers VE, Morell SA. Phosphate partition in the erythrocytes of normal newborn infants and infants with erythroblastosis fetalis. III. P32 uptake and incorporation. Blood 1962;19:468-78.
42. Greenwalt TJ, Ayers VE. Phosphate partition in the erythrocytes of normal newborn infants and infants with erythroblastosis fetalis. II. Quantitative paper chromatography. Blood 1960;15:698-705.
43. Greenwalt TJ, Ayers VE. 2,3-Diphosphoglycerate and other intraerythrocytic acid soluble phosphates in young rabbits. J Cell Comp Physiol 1959;53:307-13.
44. Greenwalt TJ, Sasaki TT. The occurrence of unexpected anti-Rh antibodies. Bibl Haematol 1959;10:207-9.
45. a). Vox Sang 1959;4:138-43.
46. Greenwalt TJ, Ayers VE. The effect of specific antibodies on the phosphate metabolism of fetal erythrocytes. Bibl Haematol 1958;14:172-4.
47. Ayers VE, Greenwalt TJ. The phosphate partition of the erythrocytes of normal newborn infants and of infants with hemolytic disease. J Clin Invest 1956;35:1404-11.
48. a. Vox Sang 1956;1:157-60.
49. Greenwalt TJ, Wagner JA. Evaluation of the quantitative direct antiglobulin test in hemolytic disease of the newborn due to anti-D. Blood 1955;10:29-34.
50. Greenwalt TJ, Triantaphyllopoulos DC. In vitro studies of red cell fragility in anti-D hemolytic disease of the newborn. J Lab Clin Med 1955;45:135-40.
51. Greenwald I. A new type of phosphoric acid compound isolated from blood, with some remarks on the effect of substitution on the rotation of λ-glyceric acid. J Biol Chem 1925;63:339-49.
52. Chanutin A, Curnish RR. The effect of adenosine, inosine, and adenine on the concentrations of organic phosphate and an electrophoretic component (B) of human red cells during storage of blood in acid-citrate-dextrose and citrate-phosphate-dextrose. Transfusion 1965;84:254-66.
53. Chanutin A. Effect of storage of blood in ACD-adenine-inorganic phosphate plus nucleosides on metabolic intermediates of human red cells. Transfusion 1967;7:409-19.
54. Chanutin A. The effect of the addition of adenine and nucleosides at the beginning of storage on the concentrations of phosphates of human erythrocytes during storage in acid-citrate-dextrose and citrate-phosphatedextrose. Transfusion 1967;7:120-32.
55. Greenwalt TJ. Leuko-agglutinins in transfusion practice. Am Pract Dig Treat 1959;10:2167-8.
56. Greenwalt TJ, Polka R. Gum acacia for preparing suspensions of leukocytes. Tech Bull Regist Med Technol 1960;30:42-5.
57. Greenwalt TJ, Gajewski inventors. Method and apparatus for treating blood. US patent 3,462,361. 1969 Aug 19.
58. Greenwalt TJ, Gajewski M, McKenna JL. A new method for preparing buffy coat-poor blood. Transfusion 1962;2:221-9. 221-9.
59. Myhre BA, Greenwalt TJ, Steane EA. A study of the D antigen by the quantitative hemagglutination technic. Bibl Haematol 1965;23:295-8.
60. Greenwalt TJ, Steane EA. Quantitative haemagglutination. 2. A method for assaying red cell antigens using the Autoanalyzer. Br J Haematol 1970;19:691-700.
61. Greenwalt TJ, Flory LL, Steane EA. Quantitative haemagglutination. 3. Studies of separated populations of human red blood cells of different densities. Br J Haematol 1970;19:701-9.
62. Greenwalt TJ, Steane EA. Quantitative haemagglutination. 5. Influence of in vivo ageing and neuraminidase treatment on the M and N antigens of human red cells. Br J Haematol 1973;25:217-26.
63. Greenwalt TJ, Steane EA. Quantitative haemagglutination. 4. Effect of neuraminidase treatment on agglutination by blood group antibodies. Br J Haematol 1973;25:207-15.
64. Greenwalt TJ, Steane EA. Quantitative haemagglutination. 6. Relationship of sialic acid content of red cells and aggregation by Polybrene, protamine and poly-L-lysine. Br J Haematol 1973;25:227-37.
65. O) antigen in erythroblastosis fetalis. J Immunol 1965;94:272-81.
66. Greenwalt TJ, Flory LL, Paige JC, Steane EA. Autoradiography of soluble metabolites in red blood cells. Transfusion 1969;9:314-6.
67. Greenwalt TJ, Paige JC, Etoh N, Steane EA. Autoradiography of diffusible compounds in human nonnucleated erythrocytes: studies with tritiated glucose and adenine. Blood 1970;35:624-36.
68. Greenwalt TJ, Steane EA. The problem of red cell polyagglutinability. Postgrad Med 1972;52:170-3.
69. Steane EA, Greenwalt TJ. Erythrocyte agglutination. Prog Clin Biol Res 1980;43:171-88.
70. Ellis FR, Friedman LI, Wirak BF, et al. A computerized national Blood Donor Deferral Register. JAMA 1975;232:722-4.
71. Ni LY, Lama S, Krakaur RB, Greenwalt TJ, Levin JJ. American National Red Cross experience with hepatitis-B antibody (HBAb or anti-HBAg) testing. Transfusion 1974;14:148-50.
72. Sandler SG, Rath CE, Wickerhauser M, Dodd RY, Greenwalt TJ. Post-Konyne hepatitis: the ineffectiveness of screening for the hepatitis B antigen (HBAg). Transfusion 1973;13:221-4.
73. Dodd RY, Holland PV, Ni LY, Smith HM, Greenwalt TJ. Hepatitis B antigen: regional variation in incidence and subtype ratio in the American Red Cross donor population. Am J Epidemiol 1973;97:111-5.
74. Dodd RY, Ni LY, Mallin WS, Greenwalt TJ. Hepatitis B (surface) antigen testing by radioimmunoassaymexperience in a very large volunteer donor population. Am J Clin Pathol 1975;63:847-53.
75. Ni LY, Dodd RY, Brown N, Salmon R, Greenwalt TJ. The solid phase radioimmunoassay technique for hepatitis B (surface) antigen: effects of progressive modification. Transfusion 1975;15:608-11.
76. Greenwalt TJ. How frequent is posttransfusion hepatitis after the introduction of 3rd generation donor screening for hepatitis B? What is its probable nature? International Forum. Vox Sang 1977;32:346-63.
77. Tabor E, Hoofnagle JH, Smallwood LA, et al. Studies of donors who transmit posttransfusion hepatitis. Transfusion 1979;19:725-31.
78. Greenwalt TJ, Flory LL, Paige JC, Steane EA. Autoradiographic studies of red cell metabolism. Bibl Haematol 1971:1416.
79. Steane EA, Greenwalt TJ. Basic mechanisms involved in antigen-antibody reactions. In: Matthes M, Nagel V, editors. Forschungsergebnisse der transfusionsmedizin and immunhaematologie. Band 2. Berlin: Medicus Verlag GmbH; 1974. p. 397-422.
80. Greenwalt TJ, Steane EA, Pine NE. Changes in erythrocyte surface antigens with aging in vivo. In: Jamieson GA, Greenwalt TJ, editors. Glycoproteins of blood cells and plasma. Philadelphia: J.B. Lippincott; 1971. p. 235-44.
81. Greenwalt TJ, Lau FO, Swierk EM, Williams RE. Studies of erythrocyte membrane loss produced by amphipathic drugs and in vitro storage. Br J Haematol 1978;39:551-7.
82. Greenwalt TJ, Lau FO, Sweeney-Hammond K, Mitten J, Cho MS. The role of micro vesiculation in erythrocyte aging. Transfusion 1979;19:638-9.
83. Greenwalt TJ, Bryan DJ, Dumaswala UJ. In vivo vesiculation of erythrocytes in sickle-cell-anemia. Clin Res 1983;31:A313.
84. Greenwalt TJ, Bryan DJ, Dumaswala UJ. Erythrocyte membrane vesiculation and changes in membrane composition during storage in citrate-phosphate- dextrose-adenine-1. Vox Sang 1984;47:261-70.
85. Greenwalt TJ, Dumaswala UJ, Bryan DJ. Erythrocyte vesiculation a mechanism of erythrocyte membrane remodeling during in-vivo and in-vitro aging. Proceedings of the ISBT, 18th Congress; Munich; 22-27 Jul 1984. p. 173.
86. Greenwalt TJ, Bryan DJ, Dumaswala UJ. Erythrocyte vesiculation in sickle-cell disease. Clin Res 1985;33:A341.
87. Greenwalt TJ, Dumaswala UJ. Effect of red cell age on vesiculation in vitro. Br J Haematol 1988;68:465-7.
88. Greenwalt TJ, Zehner SC, Dumaswala UJ. Studies in red blood cell preservation. 1. Effect of the other formed elements. Vox Sang 1990;58:85-9.
89. Greenwalt TJ, McGuinness CG, Dumaswala UJ, Carter HW. Studies in red blood cell preservation. 3. A phosphate-ammonium-adenine additive solution. Vox Sang 1990;58:94-9.
90. Greenwalt TJ, Zehner SC, Dumaswala UJ. Studies in red blood cell preservation. 2. Comparison of vesicle formation, morphology, and membrane lipids during storage in AS-1 and CPDA-1. Vox Sang 1990;58:90-3.
91. Greenwalt TJ, McGuinness CG, Dumaswala UJ. Studies in red blood cell preservation. 4. Plasma vesicle hemoglobin exceeds free hemoglobin. Vox Sang 1991;61:14-7.
92. Dumaswala UJ, Petrosky TL, Greenwalt TJ. Studies in red blood cell preservation. 6. Red cell membrane remodeling during rejuvenation. Vox Sang 1992;63:12-5.
93. Meryman HT, Hornblower ML, Syring RL. Prolonged storage of red cells at 4 degrees C. Transfusion 1986;26:500-5.
94. 4 needed to maintain red blood cell ATP during storage. Vox Sang 1992;62:136-40.
95. Greenwalt TJ, Dumaswala UJ, Dhingra N, Allen CM, Silberstein EB. Studies in red blood cell preservation: 7. In vivo and in vitro studies with a modified phosphate-ammonium additive solution. Vox Sang 1993; 65:87-94.
96. Dumaswala UJ, Levin DS, Dumaswala RU, Greenwalt TJ. Studies of red-cell membranes in a glycerol containing additive. Transfusion 1994;34:S66.
97. Greenwalt TJ, Dumaswala UJ, Rugg N. A glycerol additive solution improves red-cell viability. Transfusion 1994;34: S66.
98. Dumaswala UJ, Bentley NL, Greenwalt TJ. Studies in red blood cell preservation. 8. Liquid storage of red cells in a glycerol-containing additive solution. Vox Sang 1994;67:139-43.
99. Greenwalt TJ, Dumaswala UJ, Rugg N. Studies in red blood cell preservation. 10. Cr-51 recovery of red cells after liquid storage in a glycerol-containing additive solution. Vox Sang 1996;70:6-10.
100. Hess JR, Lippert LE, Derse-Anthony CP, et al. The effects of phosphate, pH, and AS volume on RBCs stored in saline-adenine-glucose-mannitol solutions. Transfusion 2000;40: 1000-6.
101. Hess JR, Rugg N, Knapp AD, et al. Successful storage of RBCs for 9 weeks in a new additive solution. Transfusion 2000; 40:1007-11.
102. Hess JR, Rugg N, Knapp AD, et al. Successful storage of RBCs for 10 weeks in a new additive solution. Transfusion 2000;40:1012-6.
103. Hess JR, Greenwalt TJ. Prolonged storage of red blood cells and composition. US patent 6,150,085. 2000 Nov 21.
104. Hess JR, Rugg N, Knapp AD, et al. The role of electrolytes and pH in RBC ASs. Transfusion 2001;41:1045-51.
105. Hess JR, Rugg N, Gormas JK, et al. RBC storage for 11 weeks. Transfusion 2001;41:1586-90.
106. Hess JR, Greenwalt TJ. Storage of red blood cells: new approaches. Transfus Med Rev 2002;16:283-95.
107. Hess JR, Hill HR, Oliver CK, et al. Twelve-week RBC storage. Transfusion 2003;43:867-72.
108. Hess JR, Greenwalt TJ. Prolonged storage of red blood cells. US patent 6,447,987. 2002 Sep 10.
109. Hess JR, Rugg N, Joines AD, et al. 8-week red cell storage with a conventional-volume additive solution. Transfusion 2004;44:72A.
110. Beutler E. Experimental blood preservatives for liquid storage. In: Greenwalt TJ, Jamieson GA, editors. The Human Red Cell in Vitro. The American National Red Cross 5th Annual Scientific Symposium, Washington, DC, 7-8 May, 1973, honoring Professor Alfred Chanutin, PhD, for his contributions to research in red cell metabolism and the inspiration of others. 1974. p. 189-216.